相关实验视频

Updated: Feb 6, 2026

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

有机体-免疫共同培养:一种下一代疾病建模方法

Fatemeh Najafi¹, Negin Alidoost Zoghi², Hanie Khalili³

¹Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Molecular biology reports

|February 4, 2026

概括

与免疫细胞共同培养的器官可以为癌症研究提供先进的3D模型,改善瘤微环境研究和免疫疗法评估. 这些模型提高了对免疫相互作用和药物反应的理解,为新疗法铺平了道路.

科学领域:

癌症研究癌症研究
免疫学免疫学免疫学
3D 有机体模型

背景情况:

有机器人提供了比传统模型更准确的瘤微环境 (TME) 代表.
它们可以详细研究癌细胞和免疫系统相互作用.

研究的目的:

审查有机生物与免疫细胞共同培养系统在癌症研究和免疫学中的进展和应用.
突出这些模型在研究免疫反应,免疫逃避和免疫疗法的有效性方面的潜力.

主要方法:

来自原发性瘤或干细胞的共同培养器官与各种免疫细胞 (T细胞,TIL,PBMC,NK细胞等) 相结合. ) 的情况.
利用来自肠道,胰腺,大脑,肝脏和宫组织的有机物用于特定疾病的建模.
审查使用有机平台对免疫疗法评估,药物评估和疫苗开发的研究.

主要成果:

在13种瘤类型中,器官启动成功率平均为36.8%.
有机共同培养有助于研究免疫反应,免疫逃避机制以及TME对免疫细胞的影响.
例如,模拟移植与宿主疾病,调查胰腺癌免疫抑制,评估神经母细胞瘤的工程T细胞,以及评估结肠癌中药物反应.

结论:

有机共同培养系统代表了体外癌症研究和免疫学的重大进步.
尽管在发电效率和TME模拟方面存在挑战,但正在进行的创新有望改善功能和临床相关性.
这些模型对于了解疾病机制,评估免疫疗法以及推进临床前药物和疫苗开发至关重要.

关键词:

共同文化是一种共文化.疾病建模疾病建模免疫细胞是免疫细胞.有机器人机器人机器人机器人

更多相关视频

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications

Published on: March 8, 2024

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Published on: November 12, 2015

相关概念视频

What is the Immune System?

What is the Immune System?

Model Approaches for Pharmacokinetic Data: Physiological Models

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

Model Approaches for Pharmacokinetic Data: Compartment Models

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...

Humoral Immune Responses

Humoral Immune Responses

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...